Renaissance Group’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Hold
5,236
0.01% 221
2026
Q1
$229K Buy
+5,236
New +$239K 0.01% 225
2017
Q1
Sell
-10,727
Closed -$335K 299
2016
Q4
$335K Buy
10,727
+56
+0.5% +$1.73K 0.01% 219
2016
Q3
$378K Buy
10,671
+415
+4% +$14.7K 0.02% 163
2016
Q2
$348K Buy
10,256
+614
+6% +$20.5K 0.01% 176
2016
Q1
$340K Buy
+9,642
New +$316K 0.01% 165
2015
Q2
Sell
-7,691
Closed -$312K 276
2015
Q1
$312K Buy
7,691
+265
+4% +$11K 0.01% 198
2014
Q4
$290K Buy
7,426
+475
+7% +$18K 0.01% 194
2014
Q3
$238K Buy
6,951
+402
+6% +$14.8K 0.01% 229
2014
Q2
$241K Buy
+6,549
New +$234K 0.01% 249

Other funds holding OHI

Renaissance Group's OHI Position: Q2 2026 in Review

Renaissance Group held its Omega Healthcare (OHI) position steady in Q2 2026 at 5,236 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #221.

Renaissance Group first reported a position in OHI in Q2 2014 and has held it in 10 quarters since. The position peaked at $378K in Q3 2016. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Renaissance Group held 5,236 shares of Omega Healthcare worth $250K as of Q2 2026.
  • Renaissance Group left its Omega Healthcare share count unchanged in Q2 2026.
  • Omega Healthcare made up 0.01% of Renaissance Group's portfolio in Q2 2026, its #221 holding.
  • Renaissance Group first reported a position in Omega Healthcare in Q2 2014 and has held it in 10 quarters since.
  • Renaissance Group's Omega Healthcare position peaked at $378K in Q3 2016.
  • 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.